79 related articles for article (PubMed ID: 29138376)
1. [The Changes in the Neutrophil-to-Lymphocyte Ratio Can Predict the Timing of Chemotherapeutic Regimen Alteration in Patients with Metastatic Colorectal Cancer].
Muneoka K; Shirai Y; Sasaki M; Honma S; Sakata J; Kanda J; Wakabayashi H; Wakai T
Gan To Kagaku Ryoho; 2017 Nov; 44(11):1001-1005. PubMed ID: 29138376
[TBL] [Abstract][Full Text] [Related]
2. [Change of Blood Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Metastatic Colorectal Cancer].
Muneoka K; Shirai Y; Sasaki M; Sakata J; Kanda J; Wakabayashi H; Wakai T
Gan To Kagaku Ryoho; 2017 Apr; 44(4):313-317. PubMed ID: 28428512
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis.
Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y
World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294
[TBL] [Abstract][Full Text] [Related]
4. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
5. [Selection of Chemotherapy Regimen on the Basis of Monitoring NLR and Soluble PD-L1 during CRC Chemotherapy].
Muneoka K; Shirai Y; Sasaki M; Honma S; Sakata J; Kanda J; Wakabayashi H; Wakai T; Miyazaki M
Gan To Kagaku Ryoho; 2018 Aug; 45(8):1159-1163. PubMed ID: 30158411
[TBL] [Abstract][Full Text] [Related]
6. High neutrophil-to-lymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancer.
Rossi L; Santoni M; Crabb SJ; Scarpi E; Burattini L; Chau C; Bianchi E; Savini A; Burgio SL; Conti A; Conteduca V; Cascinu S; De Giorgi U
Ann Surg Oncol; 2015 Apr; 22(4):1377-84. PubMed ID: 25234022
[TBL] [Abstract][Full Text] [Related]
7. Elevated neutrophil to lymphocyte ratio predicts poor prognosis in advanced colorectal cancer patients receiving oxaliplatin-based chemotherapy.
Kaneko M; Nozawa H; Sasaki K; Hongo K; Hiyoshi M; Tada N; Murono K; Nirei T; Kawai K; Sunami E; Tsuno NH; Kitayama J
Oncology; 2012; 82(5):261-8. PubMed ID: 22538399
[TBL] [Abstract][Full Text] [Related]
8. [Significance of preoperative neutrophil-to-lymphocyte ratio as a predictor of prognosis in patients with stage IV colorectal cancer].
Shibutani M; Maeda K; Nagahara H; Noda E; Ohtani H; Sugano K; Takii M; Kimura K; Toyokawa T; Amano R; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1603-5. PubMed ID: 24393862
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin.
Formica V; Morelli C; Ferroni P; Nardecchia A; Tesauro M; Pellicori S; Cereda V; Russo A; Riondino S; Guadagni F; Roselli M
Cancer Biomark; 2016 Sep; 17(3):335-345. PubMed ID: 27434293
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer.
Chua W; Charles KA; Baracos VE; Clarke SJ
Br J Cancer; 2011 Apr; 104(8):1288-95. PubMed ID: 21448173
[TBL] [Abstract][Full Text] [Related]
11. Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients.
Vano YA; Oudard S; By MA; Têtu P; Thibault C; Aboudagga H; Scotté F; Elaidi R
PLoS One; 2018; 13(4):e0195042. PubMed ID: 29624591
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil-lymphocyte ratio is a simple and novel biomarker for prediction of survival after radioembolization for metastatic colorectal cancer.
Tohme S; Sukato D; Chalhoub D; McDonald KA; Zajko A; Amesur N; Orons P; Marsh JW; Geller DA; Tsung A
Ann Surg Oncol; 2015 May; 22(5):1701-7. PubMed ID: 25190128
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of the advanced lung cancer inflammation index in patients with unresectable metastatic colorectal cancer: a retrospective study.
Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kimura K; Amano R; Hirakawa K; Ohira M
BMC Cancer; 2019 Mar; 19(1):241. PubMed ID: 30885163
[TBL] [Abstract][Full Text] [Related]
14. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
Shao N; Cai Q
Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
[TBL] [Abstract][Full Text] [Related]
15. A Novel Scoring System Based on Fibrinogen and the Neutrophil-Lymphocyte Ratio as a Predictor of Chemotherapy Response and Prognosis in Patients with Advanced Gastric Cancer.
Arigami T; Uenosono Y; Ishigami S; Okubo K; Kijima T; Yanagita S; Okumura H; Uchikado Y; Kijima Y; Nakajo A; Kurahara H; Kita Y; Mori S; Maemura K; Natsugoe S
Oncology; 2016; 90(4):186-92. PubMed ID: 26981856
[TBL] [Abstract][Full Text] [Related]
16. A preoperative neutrophil to lymphocyte ratio of 3 predicts disease-free survival after curative elective colorectal cancer surgery.
Malietzis G; Giacometti M; Askari A; Nachiappan S; Kennedy RH; Faiz OD; Aziz O; Jenkins JT
Ann Surg; 2014 Aug; 260(2):287-92. PubMed ID: 24096764
[TBL] [Abstract][Full Text] [Related]
17. Significance of Markers of Systemic Inflammation for Predicting Survival and Chemotherapeutic Outcomes and Monitoring Tumor Progression in Patients with Unresectable Metastatic Colorectal Cancer.
Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Yamazoe A; Kimura K; Toyokawa T; Amano R; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K
Anticancer Res; 2015 Sep; 35(9):5037-46. PubMed ID: 26254405
[TBL] [Abstract][Full Text] [Related]
18. Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: implications for clinical management.
Del Prete M; Giampieri R; Loupakis F; Prochilo T; Salvatore L; Faloppi L; Bianconi M; Bittoni A; Aprile G; Zaniboni A; Falcone A; Scartozzi M; Cascinu S
Oncotarget; 2015 Oct; 6(32):33982-92. PubMed ID: 26334693
[TBL] [Abstract][Full Text] [Related]
19. The neutrophil-to-lymphocyte ratio prechemotherapy and postchemotherapy as a prognostic marker in metastatic gastric cancer.
Kim H; Ro SM; Yang JH; Jeong JW; Lee JE; Roh SY; Kim IH
Korean J Intern Med; 2018 Sep; 33(5):990-999. PubMed ID: 29722249
[TBL] [Abstract][Full Text] [Related]
20. Preoperative neutrophil to lymphocyte ratio predicts survival in patients with T1-2N0 colorectal cancer.
Shin JS; Suh KW; Oh SY
J Surg Oncol; 2015 Nov; 112(6):654-7. PubMed ID: 26437893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
